• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞诱导的肿瘤血管生成受 TSC2-mTOR 通路调控。

Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway.

机构信息

Department of Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, PR China.

出版信息

Cancer Res. 2012 Mar 15;72(6):1363-72. doi: 10.1158/0008-5472.CAN-11-2684. Epub 2012 Jan 27.

DOI:10.1158/0008-5472.CAN-11-2684
PMID:22287548
Abstract

Tumor-associated macrophages (TAM) have multifaceted roles in tumor development but they have been associated particularly closely with tumor angiogenesis. However, although the accumulation of TAM (M2 phenotype) promotes tumor angiogenesis, the mechanism through which monocytes differentiate to generate TAM is unclear. Here, we report that the mTOR pathway is a critical element in the regulation of monocyte differentiation to TAM. In human peripheral monocytes stimulated by lipopolysaccharide, mTOR was inhibited by rapamycin or activated by RNA interference-mediated knockdown of the mTOR repressor tuberous sclerosis complex 2 (TSC2). Rapamycin caused the monocytes to differentiate into M1 macrophages releasing more interleukin (IL)-12 and less IL-10, whereas TSC2 knockdown caused the monocytes to differentiate into M2 macrophages releasing less IL-12 and more IL-10. In parallel fashion, angiogenic properties were promoted or reduced in human umbilical vein endothelial cells cocultured with TSC2-deficient monocytes or rapamycin-treated monocytes, respectively. Furthermore, tumor angiogenesis and growth in murine xenografts were promoted or reduced by infusion of hosts with TSC2-deficient or TSC2-overexpressing monocytes, respectively. Finally, in vivo depletion of macrophages was sufficient to block the antiangiogenic effects of rapamycin on tumors. Our results define the TSC2-mTOR pathway as a key determinant in the differentiation of monocytes into M2 phenotype TAM that promote angiogenesis.

摘要

肿瘤相关巨噬细胞(TAM)在肿瘤发展中具有多方面的作用,但它们与肿瘤血管生成密切相关。然而,尽管 TAM(M2 表型)的积累促进了肿瘤血管生成,但单核细胞分化为 TAM 的机制尚不清楚。在这里,我们报告 mTOR 通路是调节单核细胞分化为 TAM 的关键因素。在脂多糖刺激的人外周单核细胞中,mTOR 被雷帕霉素抑制或通过 RNAi 介导的 mTOR 抑制剂结节性硬化复合物 2(TSC2)的敲低而被激活。雷帕霉素导致单核细胞分化为释放更多白细胞介素(IL)-12 和更少 IL-10 的 M1 巨噬细胞,而 TSC2 敲低导致单核细胞分化为释放更少 IL-12 和更多 IL-10 的 M2 巨噬细胞。以类似的方式,与 TSC2 缺陷单核细胞或雷帕霉素处理的单核细胞共培养的人脐静脉内皮细胞的血管生成特性分别得到促进或减少。此外,分别输注 TSC2 缺陷或 TSC2 过表达单核细胞促进或减少了小鼠异种移植中的肿瘤血管生成和生长。最后,体内巨噬细胞耗竭足以阻断雷帕霉素对肿瘤的抗血管生成作用。我们的研究结果将 TSC2-mTOR 通路定义为决定单核细胞分化为促进血管生成的 M2 表型 TAM 的关键因素。

相似文献

1
Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway.巨噬细胞诱导的肿瘤血管生成受 TSC2-mTOR 通路调控。
Cancer Res. 2012 Mar 15;72(6):1363-72. doi: 10.1158/0008-5472.CAN-11-2684. Epub 2012 Jan 27.
2
Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis.单核细胞/巨噬细胞的募集、激活和分化调节白细胞介素-8的产生:肿瘤相关巨噬细胞在肿瘤血管生成中的旁分泌作用。
In Vivo. 2002 Nov-Dec;16(6):471-7.
3
The TSC-mTOR signaling pathway regulates the innate inflammatory response.结节性硬化症-雷帕霉素靶蛋白信号通路调节先天性炎症反应。
Immunity. 2008 Oct 17;29(4):565-77. doi: 10.1016/j.immuni.2008.08.012. Epub 2008 Oct 9.
4
Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma.ARHI 的重新表达抑制肝癌的肿瘤生长和血管生成,并损害 mTOR/VEGF 通路。
Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):417-21. doi: 10.1016/j.bbrc.2010.11.046. Epub 2010 Nov 17.
5
mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo.mTORC1 和 mTORC2 通过调节体内炎症在下肢缺血小鼠移植脂肪来源的基质细胞的功能存活中发挥不同的作用。
Stem Cells. 2013 Jan;31(1):203-14. doi: 10.1002/stem.1265.
6
Inhibition of tumor angiogenesis by interferon-γ by suppression of tumor-associated macrophage differentiation.干扰素-γ通过抑制肿瘤相关巨噬细胞分化抑制肿瘤血管生成。
Oncol Res. 2014;21(5):227-35. doi: 10.3727/096504014X13890370410285.
7
Tsc1 deficiency-mediated mTOR hyperactivation in vascular endothelial cells causes angiogenesis defects and embryonic lethality.Tsc1 缺陷导致血管内皮细胞中 mTOR 的过度激活,引起血管生成缺陷和胚胎致死。
Hum Mol Genet. 2014 Feb 1;23(3):693-705. doi: 10.1093/hmg/ddt456. Epub 2013 Sep 18.
8
Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells.哺乳动物雷帕霉素靶蛋白介导瘦素对人肝星状细胞的促血管生成作用。
Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G210-9. doi: 10.1152/ajpgi.00047.2010. Epub 2011 Jan 20.
9
Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells.直接激活 B 淋巴细胞中的 mTOR 可导致 B 细胞成熟受损和边缘区 B 细胞丢失。
Eur J Immunol. 2011 Aug;41(8):2390-6. doi: 10.1002/eji.201041336. Epub 2011 Jun 24.
10
Knockout of HIF-1α in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses.敲除肿瘤相关巨噬细胞中的 HIF-1α 可增强 M2 极化并减弱其促血管生成反应。
Carcinogenesis. 2010 Oct;31(10):1863-72. doi: 10.1093/carcin/bgq088. Epub 2010 Apr 28.

引用本文的文献

1
Lysine-Leucine-Rich Frog Skin Antimicrobial Peptides Inhibit Breast Cancer Metastasis by Reprogramming Tumor-Associated Macrophage Polarization.富含赖氨酸 - 亮氨酸的蛙皮抗菌肽通过重编程肿瘤相关巨噬细胞极化抑制乳腺癌转移。
Int J Mol Sci. 2025 Sep 4;26(17):8627. doi: 10.3390/ijms26178627.
2
mTOR Signaling in Macrophages: All Depends on the Context.巨噬细胞中的mTOR信号传导:一切取决于具体情况。
Int J Mol Sci. 2025 Aug 6;26(15):7598. doi: 10.3390/ijms26157598.
3
Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes.
由不同髓系表型驱动的转移性三阴性乳腺癌对免疫检查点抑制的反应
Commun Med (Lond). 2025 May 17;5(1):180. doi: 10.1038/s43856-025-00860-4.
4
Autophagy in tumor immune escape and immunotherapy.自噬在肿瘤免疫逃逸与免疫治疗中的作用
Mol Cancer. 2025 Mar 19;24(1):85. doi: 10.1186/s12943-025-02277-y.
5
Harnessing Macrophages in Cancer Therapy: from Immune Modulators to Therapeutic Targets.利用巨噬细胞进行癌症治疗:从免疫调节剂到治疗靶点。
Int J Biol Sci. 2025 Feb 26;21(5):2235-2257. doi: 10.7150/ijbs.106275. eCollection 2025.
6
Amino Acid Metabolism and Autophagy in Atherosclerotic Cardiovascular Disease.动脉粥样硬化性心血管疾病中的氨基酸代谢与自噬
Biomolecules. 2024 Dec 6;14(12):1557. doi: 10.3390/biom14121557.
7
RAD001-mediated mTOR targeting in human monocyte-derived dendritic cells shifts them toward an immunogenic phenotype.RAD001介导的对人单核细胞衍生树突状细胞中mTOR的靶向作用使其向免疫原性表型转变。
Immunol Res. 2024 Dec 19;73(1):21. doi: 10.1007/s12026-024-09572-8.
8
Unveiling the Role of Mechanistic Target of Rapamycin Kinase (MTOR) Signaling in Cancer Progression and the Emergence of MTOR Inhibitors as Therapeutic Strategies.揭示雷帕霉素激酶机制靶点(MTOR)信号在癌症进展中的作用以及MTOR抑制剂作为治疗策略的出现。
ACS Pharmacol Transl Sci. 2024 Nov 27;7(12):3758-3779. doi: 10.1021/acsptsci.4c00530. eCollection 2024 Dec 13.
9
HSP90 promotes tumor associated macrophage differentiation during triple-negative breast cancer progression.HSP90 促进三阴性乳腺癌进展过程中的肿瘤相关巨噬细胞分化。
Sci Rep. 2024 Sep 29;14(1):22541. doi: 10.1038/s41598-024-73394-9.
10
Dual roles of myeloid-derived suppressor cells in various diseases: a review.髓系来源抑制性细胞在多种疾病中的双重作用:综述。
Arch Pharm Res. 2024 Jul;47(7):597-616. doi: 10.1007/s12272-024-01504-2. Epub 2024 Jul 15.